Player FM uygulamasıyla çevrimdışı Player FM !
Gil Yosipovitch, MD - The Itch We Could Never Scratch: Incorporating New and Emerging Therapies to Alleviate the Burden of Prurigo Nodularis With a Team-Based Approach
Manage episode 430924088 series 103449
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until July 23, 2025.
The Itch We Could Never Scratch: Incorporating New and Emerging Therapies to Alleviate the Burden of Prurigo Nodularis With a Team-Based Approach
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Disclosure information is available at the beginning of the video presentation.
620 bölüm
Manage episode 430924088 series 103449
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until July 23, 2025.
The Itch We Could Never Scratch: Incorporating New and Emerging Therapies to Alleviate the Burden of Prurigo Nodularis With a Team-Based Approach
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Disclosure information is available at the beginning of the video presentation.
620 bölüm
Tutti gli episodi
×Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.